impact:

actelion.com

Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases. Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system disorders, irregular heart conditions, immune system disorders and cancer. One of the focuses of Actelion is treating individuals with pulmonary arterial hypertension (PAH), a heart condition that leaves patients with a short life expectancy (7–9 years) even with treatment. More information...

According to PR-model, actelion.com is ranked 645,827th in multilingual Wikipedia, in particular this website is ranked 111,519th in German Wikipedia.

The website is placed before angela-ascher.de and after graciebarrakaty.com in the BestRef global ranking of the most important sources of Wikipedia.

#Language
PR-model F-model AR-model
645,827th place
348,012th place
333,472nd place
deGerman
111,519th place
98,270th place
109,622nd place
663,152nd place
334,563rd place
432,108th place
plPolish
59,203rd place
75,086th place
41,891st place
192,046th place
157,391st place
243,922nd place
frFrench
404,079th place
427,171st place
356,896th place
109,615th place
90,145th place
100,953rd place
78,780th place
46,254th place
43,249th place
27,846th place
29,780th place
22,130th place